If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

regulatory science, cliical trials, medical device, cardiology, heart failure

Education/Academic qualification

medicine, PhD (Dr Med Sci)

Fingerprint Dive into the research topics where Koji Todaka is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Heart Failure Medicine & Life Sciences
Canidae Medicine & Life Sciences
Vagus Nerve Stimulation Medicine & Life Sciences
Dogs Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Pressure Medicine & Life Sciences
Oxygen Consumption Medicine & Life Sciences
Blood Pressure Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2018

  • 322 Citations
  • 11 h-Index
  • 26 Article
  • 1 Conference contribution
2 Citations (Scopus)
Intravenous Administration
Nanoparticles
Pharmacokinetics
Placebos
Research Personnel
11 Citations (Scopus)

Ezetimibe in combination with statins ameliorates endothelial dysfunction in coronary arteries after stenting: the CuVIC trial (effect of cholesterol absorption inhibitor usage on target vessel dysfunction after coronary stenting), a multicenter randomized controlled trial

Takase, S., Matoba, T., Nakashiro, S., Mukai, Y., Inoue, S., Oi, K., Higo, T., Katsuki, S., Takemoto, M., Suematsu, N., Eshima, K., Miyata, K., Yamamoto, M., Usui, M., Sadamatsu, K., Satoh, S., Kadokami, T., Hironaga, K., Ichi, I., Todaka, K. & 3 others, Kishimoto, J., Egashira, K. & Sunagawa, K., Feb 2017, In : Arteriosclerosis, thrombosis, and vascular biology. 37, 2, p. 350-358 9 p.

Research output: Contribution to journalArticle

Anticholesteremic Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Coronary Vessels
Randomized Controlled Trials
Coronary Angiography
1 Citation (Scopus)

Impact of Risk-Benefit Perception and Trust on Medical Technology Acceptance in Relation to Drug and Device Lag: A Tripartite Cross-Sectional Survey

Todaka, K., Kishimoto, J., Ikeda, M., Ikeda, K. & Yamamoto, H., Jan 1 2017, (Accepted/In press) In : Therapeutic Innovation and Regulatory Science. 52, 5, p. 629-640 12 p.

Research output: Contribution to journalArticle

Japan
Cross-Sectional Studies
Technology
Equipment and Supplies
Pharmaceutical Preparations
4 Citations (Scopus)

Ischemic or Nonischemic Functional Mitral Regurgitation and Outcomes in Patients With Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction

Kajimoto, K., Minami, Y., Otsubo, S., Sato, N., Sato, N., Asai, K., Munakata, R., Aokage, T., Yoshida, A., Minami, Y., Yumino, D., Mizuno, M., Kawada, E., Yoshida, K., Ozaki, Y., Kogure, T., Haruki, S., Mizuno, M., Kajimoto, K., Nakao, K. & 171 others, Sawamura, T., Nuki, T., Ishiki, R., Yokota, S., Fujinaga, H., Yamamoto, T., Harada, K., Saito, A., Kageyama, N., Okumura, T., Hata, N., Murai, K., Nozaki, A., Kawanaka, H., Tanabe, J., Sato, Y., Ishii, K., Oiwa, H., Matsumoto, T., Yoshida, D., Kato, N., Suzuki, H., Shimizu, N., Keida, T., Fujita, M., Nakamura, K., Chinen, T., Meguro, K., Kikuchi, T., Nishikido, T., Nakata, M., Yamashita, T., Nakata, M., Hirono, A., Mitsudo, K., Kadota, K., Makita, N., Watanabe, N., Kawabata, M., Fujii, K., Okuda, S., Kobayashi, S., Moriuchi, I., Mizuno, K. O., Osato, K., Murakami, T., Shimada, Y., Misawa, K., Kokado, H., Fujita, T., Fukuoka, Y., Takabatake, S., Takata, Y., Miyagi, M., Tanaka, N., Yamashina, A., Sudo, S., Shimamura, K., Nagashima, M., Kaneda, T., Ueda, K., Kato, H., Higashikata, T., Fujimori, K., Kobayashi, H., Fujii, S., Yagi, M., Ozaki, Y., Takaki, J., Yamashita, E., Toyama, T., Hirata, T., Kamisihima, K., Oka, T., Komatsu, R., Itoh, A., Naruko, T., Abe, Y., Nakagawa, E., Furukawa, A., Kinou, N., Uematsu, S., Tabuchi, I., Imai, T., sakamoto, T., Todaka, K., Koide, Y., Maemura, K., Yoshioka, K., Yoshihisa, A., Sato, T., Takeishi, Y., Ebina, T., Kimura, K., Konishi, M., Kato, M., Kinugasa, Y., Ishida, K., Sugihara, S., Yanagihara, K., Takeuchi, T., Okada, M., Hasebe, N., Sakai, T., Asano, T., Minoura, Y., Toshida, T., Sato, T., Yokota, Y., Kondo, S., Sakata, Y., Komuro, I., Otsu, K., Yamashita, S., Asano, Y., Yoshida, A., Kajimoto, K., Kashiwase, K., Ueda, Y., Kondo, T., Kawaguchi, K., Sawamura, A., Saito, T., Higa, T., Noguchi, H., Yanagita, Y., Nakamura, K., Komaki, T., Muramatsu, T., Koizumi, T., Nakajima, Y., Kikutani, T., Ikeda, Y., Tamaki, T., Funada, S., Ogawa, H., Sakuragawa, K., Kohsaka, S., Ando, S. I., Kadokami, T., Ishida, E., Ide, K., Sotomi, Y., Higuchi, Y., Uehara, M., Goto, T., Ohte, N., Miura, M., Shiba, N., Nochioka, K., Shimokawa, H., Ishihara, S., Koga, T., Fujishima, S., Kaseda, S., Haga, Y., Kida, K., Kamisihima, K., Nakamura, M., Sunagawa, O., Miyara, T., Taba, Y., Touma, T., Shinjo, O., Nishimura, Y., Kario, K., Shimizu, H., Uchida, T., Amitani, K. I., Sato, N. & Shimada, K., Sep 1 2017, In : American Journal of Cardiology. 120, 5, p. 809-816 8 p.

Research output: Contribution to journalArticle

Mitral Valve Insufficiency
Heart Failure
Confidence Intervals
Registries
Cause of Death
10 Citations (Scopus)

Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial

Kimura, K., Ikoma, A., Shibakawa, M., Shimoda, S., Harada, K., Saio, M., Imamura, J., Osawa, Y., Kimura, M., Nishikawa, K., Okusaka, T., Morita, S., Inoue, K., Kanto, T., Todaka, K., Nakanishi, Y., Kohara, M. & Mizokami, M., Sep 2017, In : EBioMedicine. 23, p. 79-87 9 p., 28844410.

Research output: Contribution to journalArticle

Catenins
Viruses
Hepacivirus
Liver
Labels